Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Rank in Stocks #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Share Price
$0.069
Last synced: 2024-07-22
Market Cap
$2.06M
Change (1 day)
-1.43%
Change (1 year)
0.00%
Country
US
Trade DermTech, Inc. (DMTK)

Category

EPS for DermTech, Inc. (DMTK)
EPS as of March 2024 TTM: $-2.70
According to DermTech, Inc. latest financial reports and stock price the company's current EPS (TTM) is $-2.70. At the end of 2022 the company had a EPS of $-3.88 an increase over its 2021 EPS that were of $-2.71.
EPS history for DermTech, Inc. from 2012 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-2.70 -12.62%
2023 $-3.09 -20.36%
2022 $-3.88 43.17%
2021 $-2.71 32.20%
2020 $-2.05 -34.50%
2019 $-3.13 -969.44%
2018 $0.36 0.00%
2017 0.00 -100.00%
2013 $-1.10 69.23%
2012 $-0.65 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$18.62 -789.63%
US
$5.65 -309.26%
US
- -
CN
$-1.36 -49.63%
US
$14.24 -627.41%
US